Variant report
Variant | esv2761406 |
---|---|
Chromosome Location | chr8:9836320-9844384 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:2)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
(count:2 , 50 per page) page:
1
No data |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs545015086 | chr8:9841613-9841614 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
2 | rs559919492 | chr8:9841634-9841635 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
3 | rs148771755 | chr8:9841664-9841665 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
4 | rs185741562 | chr8:9841688-9841689 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
5 | rs142435052 | chr8:9841693-9841694 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
6 | rs189661959 | chr8:9841714-9841715 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
7 | rs116898841 | chr8:9841723-9841724 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
8 | rs545208638 | chr8:9841744-9841745 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
9 | rs565084503 | chr8:9841747-9841748 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
10 | rs549872963 | chr8:9841819-9841820 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
11 | rs373537895 | chr8:9841822-9841823 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
12 | rs75459170 | chr8:9841829-9841830 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
13 | rs544445908 | chr8:9841839-9841840 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
14 | rs560855692 | chr8:9841883-9841884 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
15 | rs529606846 | chr8:9841918-9841919 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
16 | rs532455033 | chr8:9841926-9841927 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
17 | rs620071 | chr8:9841949-9841950 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
18 | rs566157345 | chr8:9841962-9841963 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
19 | rs527362660 | chr8:9841999-9842000 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
20 | rs566319861 | chr8:9842006-9842007 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
21 | rs532219002 | chr8:9842032-9842033 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
22 | rs116922261 | chr8:9842061-9842062 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
23 | rs182371813 | chr8:9842068-9842069 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
24 | rs34467770 | chr8:9842142-9842143 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
25 | rs537257964 | chr8:9842181-9842182 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
26 | rs557654723 | chr8:9842205-9842206 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
27 | rs567983393 | chr8:9842207-9842208 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
28 | rs150901671 | chr8:9842218-9842219 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
29 | rs139433376 | chr8:9842224-9842225 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
30 | rs1521195 | chr8:9842234-9842235 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
31 | rs144176192 | chr8:9842262-9842263 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
32 | rs568752408 | chr8:9842268-9842269 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
33 | rs369046240 | chr8:9842286-9842287 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
34 | rs545483275 | chr8:9842297-9842298 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
35 | rs537064059 | chr8:9842324-9842325 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
36 | rs548820404 | chr8:9842329-9842330 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
37 | rs372446120 | chr8:9842365-9842366 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
38 | rs570235130 | chr8:9842401-9842402 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
39 | rs575352733 | chr8:9842408-9842409 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
40 | rs544016522 | chr8:9842426-9842427 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
41 | rs114752942 | chr8:9842442-9842443 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
42 | rs187239403 | chr8:9842446-9842447 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
43 | rs76494968 | chr8:9842450-9842451 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
44 | rs566404289 | chr8:9842466-9842467 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
45 | rs192071022 | chr8:9842474-9842475 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
46 | rs147780467 | chr8:9842523-9842524 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
47 | rs534707689 | chr8:9842557-9842558 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
48 | rs552209150 | chr8:9842598-9842599 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
49 | rs141193899 | chr8:9842666-9842667 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
50 | rs370191716 | chr8:9842668-9842669 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Crohn''s disease | 19220326 | CNVD |
Psoriasis | 19220326 | CNVD |
Prostate cancer | 21965145 | CNVD |
Prostate cancer | 18515986 | CNVD |
Chronic obstructive pulmonary disease | 20378733 | CNVD |
Autism | 18414403 | CNVD |
Cancer | 21183584 | CNVD |
Non-syndromic sensorineural hearing loss | 15273396 | CNVD |
Breast cancer | 17603634 | CNVD |
Myeloproliferative neoplasm | 20015882 | CNVD |
Ovarian cancer | 20844748 | CNVD |
Cervical cancer | 17311676 | CNVD |
High-grade prostatic intraepithelial neoplasia | 16573809 | CNVD |
Non-syndromic sensorineural hearing loss | 20606397 | CNVD |
Schizophrenia | 20877625 | CNVD |
Disorders of sex development | 21048976 | CNVD |
Colorectal cancer | 16272173 | CNVD |
Basal cell lymphoma | 17170743 | CNVD |
Follicular lymphoma | 17170743 | CNVD |
Breast cancer | 17001317 | CNVD |
Thyroid cancer | 19087340 | CNVD |
Multiple myeloma | 16616336 | CNVD |
Hepatocellular carcinoma | 22174799 | CNVD |
Heart disease | 21282601 | CNVD |
Prostate cancer | 16573809 | CNVD |
T-cell lymphomas | 19863542 | CNVD |
Ovarian cancer | 22174824 | CNVD |
Colorectal cancer | 21297112 | CNVD |
Hodgkin''s lymphoma | 18641027 | CNVD |
Salivary gland tumor | 18059337 | CNVD |
Breast cancer | 17133270 | CNVD |
Melanoma | 18172304 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Chronic lymphocytic leukemia | 18922857 | CNVD |
Breast cancer | 17393978 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Cancer | 21637783 | CNVD |
Breast cancer | 20837533 | CNVD |
Squamous cell cancer | 21044232 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Cancer | 22429812 | CNVD |
Non-small cell lung cancer | 21044232 | CNVD |
Non-syndromic sensorineural hearing loss | 18471307 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Colorectal cancer | 20709793 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Basal cell lymphoma | 21115979 | CNVD |
Breast cancer | 21264507 | CNVD |
Carcinoma ex pleomorphic adenoma | 18828159 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Oral cancer | 21386901 | CNVD |
Prostate cancer | 21088497 | CNVD |
Breast cancer | 20940404 | CNVD |
Colorectal cancer | 19359472 | CNVD |
Embryonal rhabdomyosarcoma | 16790082 | CNVD |
Gastric cancer | 17167181 | CNVD |
Prostate cancer | 16705090 | CNVD |
8p-syndrome | 17576883 | CNVD |
Human rectal carcinomas | 16397240 | CNVD |
Medulloblastoma | 16968546 | CNVD |
Lung adenocarcinoma | 19525976 | CNVD |
Lung cancer | 19525976 | CNVD |
Prostate cancer | 17245344 | CNVD |
Gastrointestinal stromal cancer | 16982739 | CNVD |
Cancer | 16751803 | CNVD |
Wilms tumour | 21544195 | CNVD |
Gastric cancer | 17908304 | CNVD |
Autism | 19415332 | CNVD |
Malaria | 21533027 | CNVD |
Non-syndromic sensorineural hearing loss | 22037309 | CNVD |
Esophageal cancer | 21851588 | CNVD |
Acute promyelocytic leukemia | 19109227 | CNVD |
Breast cancer | 21245420 | CNVD |
Acute lymphoblastic leukemia | 21248843 | CNVD |
Breast cancer | 21785460 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
Breast cancer | 21509527 | CNVD |
T-cell prolymphocytic leukemia | 17713554 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
Acute myeloid leukemia | 21251322 | CNVD |
Prostate cancer | 18632612 | CNVD |
Breast cancer | 21858162 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Liver carcinoma | 19366792 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Congenital diaphragmatic hernia | 21064195 | CNVD |
Autism | 22495311 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Intellectual disability | 22045946 | CNVD |
Malignant fibrous histiocytomas | 21085701 | CNVD |
Breast cancer | 16608533 | CNVD |
Seminomas | 18059402 | CNVD |
Lung cancer | 18438408 | CNVD |
Lung squamous cell carcinoma | 22363434 | CNVD |
Medulloblastoma | 16783165 | CNVD |
Gastric cancer | 18160780 | CNVD |
Breast cancer | 21990379 | CNVD |
Psoriasis | 20403174 | CNVD |
Psoriasis | 20663923 | CNVD |
Crohn''s disease | 16909382 | CNVD |
Cancer | 21129771 | CNVD |
Congenital diaphragmatic hernia | 21085971 | CNVD |
Crohn''s disease | 20877625 | CNVD |
Inflammatory disorder | 20877625 | CNVD |
Cardiac defect | 21933911 | CNVD |
Psoriasis | 18059266 | CNVD |
Barrett''s adenocarcinoma | 18663352 | CNVD |
Psoriasis | 20877625 | CNVD |
Mental retardation | 17847001 | CNVD |
Prostate cancer | 17217626 | CNVD |
Schizophrenia | 21399695 | CNVD |
Colorectal cancer | 21128281 | CNVD |
Colorectal cancer | 19455253 | CNVD |
Psoriasis | 18848619 | CNVD |
Squamous cell cancer | 19047905 | CNVD |
Colorectal cancer | 17229543 | CNVD |
Gastrointestinal stromal cancer | 19259404 | CNVD |
Malignant peripheral nerve sheath tumor | 18522746 | CNVD |
Myxofibrosarcoma | 16751306 | CNVD |
Immune disease | 21572526 | CNVD |
Non-small cell lung cancer | 21829676 | CNVD |
Ovarian neoplasms | 16753589 | CNVD |
Kallmann Syndrome 2 | 22470819 | CNVD |
Developmental disorder | 20461109 | CNVD |
abnormal development | 18461090 | CNVD |
Ovarian clear cell carcinoma | 21343371 | CNVD |
Glioblastoma multiforme | 21138945 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Breast cancer | 21364760 | CNVD |
Pancreatic ductal adenocarcinoma | 19077451 | CNVD |
Bipolar disorder | 19114987 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr8:9841600-9842600 | Enhancers | iPS-20b Cell Line | embryonic stem cell |
2 | chr8:9841800-9842600 | Enhancers | iPS-18 Cell Line | embryonic stem cell |
3 | chr8:9842000-9842400 | Enhancers | iPS DF 19.11 Cell Line | embryonic stem cell |
4 | chr8:9842000-9842600 | Enhancers | H1 Cell Line | embryonic stem cell |
5 | chr8:9842000-9842600 | Enhancers | H9 Cell Line | embryonic stem cell |
6 | chr8:9842000-9842600 | Enhancers | HUES48 Cell Line | embryonic stem cell |
7 | chr8:9842000-9842600 | Enhancers | iPS-15b Cell Line | embryonic stem cell |
8 | chr8:9842400-9842800 | Enhancers | ES-UCSF4 Cell Line | embryonic stem cell |
9 | chr8:9842400-9855000 | Weak transcription | iPS DF 19.11 Cell Line | embryonic stem cell |
10 | chr8:9842600-9848000 | Weak transcription | iPS-20b Cell Line | embryonic stem cell |
11 | chr8:9842600-9848200 | Weak transcription | HUES48 Cell Line | embryonic stem cell |
12 | chr8:9842800-9848000 | Weak transcription | ES-UCSF4 Cell Line | embryonic stem cell |
13 | chr8:9843400-9844000 | Enhancers | Liver | Liver |